PetCaseFinder

Peer-reviewed veterinary case report

Prognostic value of tumour-related factors associated with canine retroperitoneal hemangiosarcoma in comparison with other anatomic presentations: A retrospective observational study.

Journal:
Veterinary medicine and science
Year:
2024
Authors:
Furukawa, Takayuki et al.
Affiliation:
Japan Animal Referral Medical Center (Nagoya) · Japan
Species:
dog

Abstract

BACKGROUND: Dogs with retroperitoneal hemangiosarcoma (HSA) exhibit variable postoperative median survival times (MST). OBJECTIVE: To retrospectively evaluate the prognostic value of selected tumour-related factors, such as tumour size, rupture, invasion into adjacent tissue, involvement of lymph node and distant metastasis, they were analysed in dogs with retroperitoneal HSA. METHODS: Ten dogs with retroperitoneal HSA managed solely with surgical excision were reviewed and compared with spleen (71) and liver (9) HSA. The Kaplan-Meier method and log-rank analysis were used compare MSTs between factors. Multivariable Cox proportional-hazard analysis was used to compare differences between arising sites. RESULTS: Retroperitoneal HSA showed comparatively longer postoperative MST compared with that of spleen and liver HSA and demonstrated significantly longer MST (p&#xa0;=&#xa0;0.003) for tumours &#x2265;5&#xa0;cm (195 days) than <5&#xa0;cm (70 days). Spleen HSA revealed significantly shorter MSTs in involvement of distant lymph nodes (23 days) and distant metastasis (39 days) than those in negative (83 days, p&#xa0;=&#xa0;0.002 and 110 days, p&#xa0;<&#xa0;0.001, respectively). Liver HSA also revealed significantly shorter MST (16.5 days compared with 98 days, p&#xa0;=&#xa0;0.003) for distant metastasis. Additionally, hazard ratios (HRs) and their forest plot for overall HSA revealed as poor prognostic factors, arising sites (spleen; HR 2.78, p&#xa0;=&#xa0;0.016 and liver; HR 3.62, p&#xa0;=&#xa0;0.019), involvement of distant lymph nodes (HR 2.43, p&#xa0;=&#xa0;0.014), and distant metastasis (HR 2.86, p&#xa0;<&#xa0;0.001), and as better prognostic factor of tumour size &#x2265;5&#xa0;cm (HR 0.53, p&#xa0;=&#xa0;0.037). CONCLUSION: In combination with overall HSA, retroperitoneal HSA shows comparatively longer postoperative MST compared to spleen and liver HSA, associated with tumour size &#x2265;5&#xa0;cm suggesting better prognostic factor.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication: https://pubmed.ncbi.nlm.nih.gov/38889089/